Quidel

Quidel Cash Flow per Share

The Operating Cash Flow per Share of Quidel (QDEL) as of Nov 5, 2026 is 1.55 USD. In the previous year, Operating Cash Flow per Share was 1.24 USD — a change of 25.63% (higher).

Cash Flow per Share

1.55USD

YoY

25.63%

Last updated:

Operating Cash Flow per Share of Quidel is 2025 1.55 USD. Operating Cash Flow per Share of Quidel was 2024 1.24 USD. It decreases by 25.63% higher compared to the previous year.

The Quidel Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
3.18 USD
Jan 1, 2019
3.11 USD
Jan 1, 2020
14.44 USD
Jan 1, 2021
18.96 USD
Jan 1, 2022
13.23 USD
Jan 1, 2023
4.16 USD
Jan 1, 2024
1.24 USD
Jan 1, 2025
1.55 USD
The Quidel Cash Flow per Share history
YEARCash Flow per ShareYoY
1.55USD+25.63%
1.24USD-70.33%
4.16USD-68.54%
13.23USD-30.21%
18.96USD+31.35%
14.44USD+364.70%
3.11USD-2.44%
3.18USD+294.57%
0.81USD+124.70%
0.36USD-66.84%
1.08USD+11.05%
0.98USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quidel Stock analysis

What does Quidel do? Quidel Corporation is a US-based company specializing in the production of rapid tests for medical diagnostics. It was founded in 1979 and is headquartered in San Diego, California. Since 1991, it has been listed on the NASDAQ stock exchange. Quidel initially started as Diagnostic Reagents Laboratory (DRL) and focused on manufacturing diagnostic products for the veterinary sector. In 1990, it was renamed Quidel Corporation and expanded its operations into human diagnostics. The company's business model revolves around the development and production of immunological rapid tests that can quickly and easily diagnose infectious diseases and other health problems. Quidel focuses on creating high-quality, accurate, and cost-effective test procedures that can be used by healthcare professionals or even laypersons at home. One of Quidel's core competencies is bringing to market rapid tests that are easy to perform and provide immediate results without the need to send samples to a laboratory. The company offers a wide range of rapid tests for diagnosing various diseases. These include tests for infectious diseases such as influenza, streptococcus, Lyme disease, and chlamydia, as well as tests for pregnancy, drug abuse, and cardiovascular diseases. The tests are available as single tests or panel tests that can diagnose multiple diseases simultaneously. Quidel operates in four business segments: Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassays, and Specialized Diagnostic Solutions. The Molecular Diagnostics segment focuses on developing molecular diagnostic tests and instruments for laboratory use. The Point-of-Care Diagnostics segment develops and produces rapid tests for use in medical practices and hospitals. The Immunoassays segment specializes in reagent-based tests for the quantitative analysis of biomolecules. The Specialized Diagnostic Solutions segment includes specialized diagnostic products, such as test systems for monitoring antibiotic therapies. In conclusion, Quidel Corporation specializes in the development and production of rapid tests for medical diagnostics. The company offers a wide range of high-quality, accurate, and cost-effective test procedures for diagnosing infectious diseases, pregnancy, drug abuse, and cardiovascular diseases. Quidel has gained a significant market share in the diagnostics field through its rapid tests and diverse range of test panels for various conditions, and it is known for its innovative products. Quidel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quidel stock

Operating Cash Flow per Share of Quidel is 1.55 USD in 2025.

Operating Cash Flow per Share of Quidel changed from 1.24 USD to 1.55 USD, representing a 25.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Quidel since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Quidel

All Key Metrics — Quidel